Cellens Inc

Sensing Cancer on a Nanoscale Level

Boston, United States · Founded 2021 · $6.5M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$6.5M
Last Round
$6.5M SeedDec 2025
Rounds
1

About

Cellens is a Boston-based Tufts University spinout pioneering a non-invasive cancer diagnostics platform that uses nanoscale mechanobiology and machine learning to detect bladder cancer from urine samples. Its Octosense platform scans cell surfaces at nanoscale resolution to identify unique biophysical fingerprints of cancer cells. The company raised a $6.5M seed round in December 2025 to advance its AI-driven diagnostic technology.

Summary

Cellens Inc is a Biotech company based in Boston, United States, founded in 2021. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Dec 2025. Investors include SOSV, American Cancer Society BrightEdge Fund and KOLON.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2025
$6.5M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellens Inc on Indexed.vc
<a href="https://indexed.vc/companies/cellens-inc"><img src="https://indexed.vc/api/badge/company/cellens-inc" alt="Cellens Inc on Indexed.vc" width="260" height="76" /></a>